Rubraca - direct healthcare professional communication (DHPC)

Rucaparib camsylate

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Rubraca (rucaparib): restriction of indication

Key facts

• Medicine name:
  Rubraca
• Active substance:
  Rucaparib camsylate
• Therapeutic area (MeSH):
  Ovarian Neoplasms
• Procedure number:
  EMEA/H/A-20/1518/C/4272/0033
• Regulatory outcome:
  Variation
• DHPC type:
  • Referral - Article 20 procedure
  • Restriction of indication
• Human ATC codes:
  L01XX
• Dissemination date:
  12/08/2022